文献速递神经肿瘤小儿神经外科与脑积水

重新审视儿童低级别胶质瘤背景下的毛细胞型星形细胞瘤

Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas.
PubMed 文献 · Neuro Oncol · 2021-01-01

儿童低级别胶质瘤(pLGG)是儿童最常见的脑肿瘤,与终身临床疾病负担相关。本文综述了pLGG特别是毛细胞型星形细胞瘤(PA)的当前认识,指出尽管多数致病驱动突变集中于MAPK/ERK通路,但可能不足以独立导致胶质瘤发生,并提出了未来机制研究的概念框架及社区面临的挑战。

要点

  • pLGG是儿童最常见脑肿瘤,与终身临床疾病负担相关。
  • 多数致病驱动突变集中于MAPK/ERK通路,但可能不足以独立驱动肿瘤发生。
  • pLGG缺乏经认证的临床前模型,分子细胞发病机制认识不完整。

核心结论

  • pLGG的致病驱动突变多集中于MAPK/ERK通路,但可能不足以独立导致胶质瘤发生与临床进展。

研究设计与样本

  • 综述,基于大规模基因组分析等现有文献,讨论pLGG及毛细胞型星形细胞瘤的当前认识、机制研究框架与挑战。

主要发现

  • pLGG是儿童最常见脑肿瘤,与终身临床疾病负担相关。
  • 相对成人高级别胶质瘤或其他儿童恶性脑肿瘤,pLGG缺乏经认证的临床前模型。
  • 大规模基因组分析已识别多数致病驱动突变,集中于MAPK/ERK信号通路。

局限性

  • pLGG的分子和细胞发病机制认识不完整,且缺乏经认证的临床前模型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pediatric low-grade gliomas (pLGGs) are the most common brain tumor in children and are associated with lifelong clinical morbidity. Relative to their high-grade adult counterparts or other malignant childhood brain tumors, there is a paucity of authenticated preclinical models for these pLGGs and an incomplete understanding of their molecular and cellular pathogenesis. While large-scale genomic profiling efforts have identified the majority of pathogenic driver mutations, which converge on the MAPK/ERK signaling pathway, it is now appreciated that these events may not be sufficient by themselves for gliomagenesis and clinical progression. In light of the recent World Health Organization reclassification of pLGGs, and pilocytic astrocytoma (PA), in particular, we review our current understanding of these pediatric brain tumors, provide a conceptual framework for future mechanistic studies, and outline the challenges and pressing needs for the pLGG clinical and research communities.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Milde T, Rodriguez FJ, Barnholtz-Sloan JS, et al. Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas. Neuro Oncol. 2021. PMID: 34131743. doi:10.1093/neuonc/noab138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。